Establishment Labs Holdings (ESTA) Share-based Compensation (2020 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Share-based Compensation of $3.0 million in Q1 2026, up 3.48% quarter-over-quarter from $2.9 million in Q4 2025, and up 23.38% on a YoY basis from $2.4 million in Q1 2025.
Establishment Labs Holdings (ESTA) Share-based Compensation (2020 - 2026) Analysis & Trends
Establishment Labs Holdings' Share-based Compensation history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 23.38% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $12.0 million (down 10.53% YoY), while the FY2025 annual figure was $11.4 million, down 20.75% from the prior year.
- Share-based Compensation was $3.0 million for Q1 2026 at Establishment Labs Holdings, up from $2.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.0 million in Q3 2023 to a low of $2.4 million in Q1 2025.
- Historically, Share-based Compensation has averaged $3.3 million across 5 years, with a median of $3.4 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation soared 95.56% in 2022, then dropped 29.33% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $3.3 million in 2022, then advanced by 5.86% to $3.5 million in 2023, then grew by 2.75% to $3.5 million in 2024, then declined by 18.16% to $2.9 million in 2025, then gained by 3.48% to $3.0 million in 2026.
- The last three Share-based Compensation figures came in at $3.0 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2023 | 3.45 Mn |